A certain protein builds up in the brains of most Parkinson's patients, a study confirmed on Thursday using a new technique hailed as a potential "game-changer" that could point towards a way to test for the debilitating ...
Apr 15, 2023
0
64
The Lancet Neurology has published data from the phase 3 MycarinG study evaluating the efficacy and safety of rozanolixizumab in adult patients with acetylcholine receptor autoantibody-positive (AChR-Ab+) or muscle-specific ...
Apr 13, 2023
0
21
Together with multiple sclerosis (MS) experts, biostatisticians and clinicians from across the globe, a UK HealthCare neurologist has helped compile an essential list of MS medications for patients in resource-poor settings.
Mar 2, 2023
0
12
An international panel led by a pediatric neuroimmune expert and co-director of the Neuroscience Center at Children's Hospital of Philadelphia (CHOP) has established new criteria for properly diagnosing myelin oligodendrocyte ...
Feb 16, 2023
0
19
US pharmaceutical giant Pfizer has obtained positive results in late-stage testing for a nasal spray designed to treat migraines, a study showed Thursday.
Feb 16, 2023
0
19
A universal criteria for diagnosing the blinding eye condition optic neuritis has been developed by a UCL-led team of researchers.
Jan 12, 2023
0
4
Amyloid plaques—protein clumps that are one of the hallmarks of Alzheimer's disease—occur at roughly the same level in the brains of people with Down syndrome who have Alzheimer's as they do in people with forms of hereditary, ...
Dec 13, 2022
0
45
A team of experts encouraged ongoing investigation of the benefits of exercise training for individuals with multiple sclerosis, citing shortcomings of available studies. They outlined their outlook for this avenue of research ...
Jul 19, 2022
0
5
Patients with multiple sclerosis (MS) treated with the drug rituximab had a significantly lower risk of relapse compared with MS patients receiving standard treatment. This has been shown in a phase 3 clinical trial by researchers ...
Jul 13, 2022
0
64
A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; this 'significant' ...
Jun 16, 2022
0
11
